Source:

Healio Interview

Disclosures: Markman reports a consultant role with Merck related to the company’s anti-cancer drug therapeutics.
January 18, 2022
1 min watch
Save

HPV vaccination results in ‘real’ reduction in cervical cancer

Source:

Healio Interview

Disclosures: Markman reports a consultant role with Merck related to the company’s anti-cancer drug therapeutics.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In the second installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about the impact of HPV vaccination on the global burden of cervical cancer.

Trial data have showed vaccination prevents up to 99% of cervical cancer precursor lesions, according to Markman, president of medicine and science at Cancer Treatment Centers of America and a HemOnc Today Editorial Board member.

More recent data from Sweden, Great Britain and the United States — including a study published last year in JAMA Pediatrics — showed a reduction in cervical cancer already is being seen.

“It’s real, and it’s very easy to document,” Markman said.